Personal Genomics
Focus: Personal Genomics is a Taiwan-based biotechnology company founded in 1999 specializing in NGS (next-generation sequencing) for diagnostic applications, primarily in infectious diseases. The company is publicly listed and operates as a mid-cap biotech focused on molecular diagnostics.
Profile data last refreshed 6h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
0
About Personal Genomics
AI assessmentNot HiringNo open roles listed right now. Follow Personal Genomics to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Personal Genomics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
MONISTAT DUAL-PAK
Declining
LOE Approaching
Mature topical antifungal at end-of-life; represents legacy revenue unrelated to core NGS diagnostic business.
Help build intelligence for Personal Genomics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.